Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/2010
12/16/2010US20100317828 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants
12/16/2010US20100317827 Method of Purifying a Peptide
12/16/2010US20100317826 Neoplasm specific antibodies and uses thereof
12/16/2010US20100317601 Casein Derived Peptides And Uses Thereof
12/16/2010US20100317600 Process for Preparing Cardiodilatin Fragments; Highly Purified Cardiodilatin Fragments and Intermediate Products for the Preparation of Same
12/16/2010US20100317593 2,3-dihydro-1h-indene compounds
12/16/2010US20100317577 Methods and Compositions for Inhibiting Cell Death or Enhacing Cell Proliferation
12/16/2010US20100317566 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
12/16/2010US20100317565 Novel Peptides and Their Use for the Treatment of Edema
12/16/2010US20100317564 Immunoregulatory peptides and methods of use
12/16/2010US20100317050 Polypeptides for microbial detection
12/16/2010US20100317044 Mass spectrometric endopeptidase assay
12/16/2010US20100317025 Diagnostic Method for Celiac Sprue
12/16/2010US20100316648 Novel plasminogen receptor, polypeptides and antibodies thereof
12/16/2010US20100316643 Targeted antimicrobial moieties
12/16/2010US20100316616 Use of FZC18-Containing Collagen 18 Polypeptides for the Treatment, Diagnosis and Outcome Prediction of Diseases
12/16/2010US20100316574 Oncofetal Antigen/Immature Laminin Receptor Peptides for the Sensitization of Dendritic Cells for Cancer Therapy
12/16/2010US20100316569 Novel peptides
12/16/2010CA2768246A1 Serine rich peptides having antioxidative stress properties
12/16/2010CA2764797A1 Melanocortin receptor-specific peptides
12/16/2010CA2764760A1 Identification, optimization and use of shared hla-b*0702 epitopes for immunotherapy
12/16/2010CA2761607A1 Melanocortin receptor-specific peptides
12/16/2010CA2761121A1 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
12/15/2010EP2261380A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261378A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261377A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261376A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261375A2 Method of Preventing Virus:Cell Fusion By Inhibiting the Function of the Fusion Initiation Region in RNA Viruses Having Class I Membrane Fusogenic Envelope Proteins
12/15/2010EP2261374A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins
12/15/2010EP2261317A1 Microorganism producing cyclic compound
12/15/2010EP2261249A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261248A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261246A2 Binding polypeptides for B-lymphocyte stimulator protein (BLyS)
12/15/2010EP2261238A1 Cyclic compound and salt thereof
12/15/2010EP2261237A2 Daptomycin and related analogs in crystalline form, their preparation and use
12/15/2010EP2260859A1 Compounds acting as peptide gap junction modulators and their uses
12/15/2010EP2260858A2 Monomethylvaline compounds capable of conjugation to ligands
12/15/2010EP2260053A1 Oxytocin analogues
12/15/2010EP1635855B1 Selective r-cadherin antagonists and methods
12/15/2010EP1053001B1 Novel mixed amylin activity compounds
12/15/2010CN1852920B Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
12/15/2010CN101918433A Peptides specific for hepatocellular carcinoma cells and applications thereof
12/15/2010CN101918432A Synthetic peptides immuno-reactive with rheumatoid arthritis auto-antibodies
12/15/2010CN101918431A Cell-permeabilising peptides and polypeptides for microbial cells
12/15/2010CN101918429A Peptide production and purification process
12/15/2010CN101914150A Polypeptide and use thereof in medicament preparation
12/15/2010CN101914141A Phosphorescent iridium complex capable of targeting tumor cell
12/15/2010CN101914140A Scorpion source antivirus active polypeptide and application thereof
12/15/2010CN101914139A Human papilloma virus (HPV) capsid protein L1 polypeptide and preparation and application thereof
12/15/2010CN101914138A Hepatoma-targeting peptide-doxorubicin prepared from coupling agent and synthetic method
12/15/2010CN101914137A Liver cancer target peptide-doxorubicin and preparation method thereof
12/15/2010CN101914136A Liquid-phase synthesis method for oxytocin
12/15/2010CN101914135A Broad-spectrum chemokine receptor antagonistic polypeptide and application thereof
12/15/2010CN101914134A Linear epitope minimum motif peptide of human papilloma virus type 58 E7 protein
12/15/2010CN101357945B Synthetic peptide coupling antigen and reagent for testing porcine circovurus type 2 specific antibody
12/14/2010US7851598 Receptor modulators
12/14/2010US7851591 peptide that binds to a human major histocompatibility complex class I A molecule; for treating a patient that has or is at risk of having a cell that expresses telomerase catalytic subunit (hTERT)
12/14/2010US7851587 Peptides derived from the C2 domain of epsilon PKC
12/14/2010US7851444 χ-conotoxin peptides (-1)
12/14/2010CA2285937C Modified proteins which bind extracellular matrix components
12/14/2010CA2205007C Antibody against human interleukin-5 receptor .alpha. chain
12/09/2010WO2010141845A2 Immunoregulatory peptides and methods of use
12/09/2010WO2010141421A1 Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases
12/09/2010WO2010141276A1 Solid phase peptide synthesis process for the production of goserelin
12/09/2010WO2010140567A1 Endokinin c/d-origin peptides
12/09/2010WO2010139048A1 Human milk peptides
12/09/2010WO2010119450A3 An improved process for the preparation of desmopressin or its pharmaceutically acceptable salts
12/09/2010US20100313281 Variants and methods of using transforming growth factor beta-9
12/09/2010US20100311947 Polypeptide cleavage process
12/09/2010US20100311946 Solid Phase Peptide for the Production of Goserelin
12/09/2010US20100311944 Cyclosporine analogue mixtures and their use as immunomodulating agents
12/09/2010US20100311648 Melanocortin receptor-specific peptides
12/09/2010US20100311644 Isozyme-specific antagonists of protein kinase c
12/09/2010US20100311641 Peptide-based body surface coloring reagents
12/09/2010US20100311640 Self-assembling peptide incorporating modifications and methods of use thereof
12/09/2010US20100311184 Azo heterocyclic dyes and their biological conjugates
12/09/2010US20100311097 Stable isotope labeled polypeptide standards for protein quantitation
12/09/2010US20100310644 Anti-dandruff compositions containing peptides
12/09/2010US20100310640 Hla-dr binding peptides and their uses
12/09/2010US20100310635 Compositions and Methods for Regulating T-Cell Activity
12/09/2010US20100310591 Ii-KEY HYBRID PEPTIDES THAT MODULATE THE IMMUNE RESPONSE TO INFLUENZA
12/09/2010US20100310531 Peptide-coated cell localization to diseased or damaged tissues and methods related thereto
12/09/2010US20100310484 Novel peptides, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same
12/09/2010US20100310459 Targeted Detection of Dysplasia In Barrett's Esophagus With A Novel Fluorescence-Labeled Polypeptide
12/09/2010CA2764164A1 Immunoregulatory peptides and methods of use
12/09/2010CA2764153A1 Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases
12/09/2010CA2763977A1 Human milk peptides
12/08/2010EP2258715A1 Kahalalide compounds
12/08/2010EP2258714A1 Improved analytical method for the detection of latent hepatitis c, use thereof and corresponding diagnosis kit
12/08/2010EP2257314A2 Peptide targeting imaging agents and methods of use thereof
12/08/2010EP2076528B1 Purification processes of echinocandin-type compounds
12/08/2010EP1864995B1 Beta-lactamic rgd cyclopeptides containing gamma turns
12/08/2010EP1598369B1 Anti tgr23-2 ligand antibodies and uses thereof
12/08/2010EP1572726B1 4-methylhexanoic kahalalide f compound
12/08/2010EP1551867B1 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions
12/08/2010EP1438329B1 Biologically active peptides and their use for repairing injured nerves
12/08/2010CN1948333B New hPEBP4 protein source HLA-A2 limiting epi-polypeptide and its application
12/08/2010CN1650005B Antimicrobial polypeptide and utizliation thereof
12/08/2010CN101906464A Proteins producing an altered immunogenic response and methods of making and using the same
12/08/2010CN101906163A Immunocontraceptive synthetic peptide and immunocontraceptive chimeric peptide and application thereof
1 ... 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 ... 423